- Home
- JMIA vs HROW Comparison
JMIA vs HROW Comparison
Compare JMIA & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMIA
- HROW
- Stock Information
- Founded
- JMIA 2012
- HROW 1998
- Country
- JMIA Germany
- HROW United States
- Employees
- JMIA N/A
- HROW N/A
- Industry
- JMIA Catalog/Specialty Distribution
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- JMIA Consumer Discretionary
- HROW Health Care
- Exchange
- JMIA Nasdaq
- HROW Nasdaq
- Market Cap
- JMIA 949.1M
- HROW 1.1B
- IPO Year
- JMIA 2019
- HROW N/A
- Fundamental
- Price
- JMIA $7.88
- HROW $39.12
- Analyst Decision
- JMIA Hold
- HROW Strong Buy
- Analyst Count
- JMIA 1
- HROW 7
- Target Price
- JMIA $4.75
- HROW $64.67
- AVG Volume (30 Days)
- JMIA 5.6M
- HROW 674.5K
- Earning Date
- JMIA 08-07-2025
- HROW 08-11-2025
- Dividend Yield
- JMIA N/A
- HROW N/A
- EPS Growth
- JMIA N/A
- HROW N/A
- EPS
- JMIA N/A
- HROW N/A
- Revenue
- JMIA $164,022,000.00
- HROW $227,661,000.00
- Revenue This Year
- JMIA $8.75
- HROW $46.17
- Revenue Next Year
- JMIA $9.21
- HROW $39.97
- P/E Ratio
- JMIA N/A
- HROW N/A
- Revenue Growth
- JMIA N/A
- HROW 47.69
- 52 Week Low
- JMIA $1.60
- HROW $20.85
- 52 Week High
- JMIA $8.17
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- JMIA 72.42
- HROW 65.08
- Support Level
- JMIA $6.86
- HROW $36.55
- Resistance Level
- JMIA $8.17
- HROW $40.61
- Average True Range (ATR)
- JMIA 0.62
- HROW 2.44
- MACD
- JMIA 0.09
- HROW 0.31
- Stochastic Oscillator
- JMIA 91.83
- HROW 86.28
About JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.